It depends on your body weight, goals, and activity level but most adults on GLP-1s need more protein than their reduced appetite naturally allows
Ozempic Use Linked to Vision Loss and NAION Study Highlight: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide In July 2024, researchers at Mass Eye and Ear found a potential link between the use of semaglutide and an increased risk of developing NAOIN, a rare but serious condition
Taking the Next Step Deciding to move from medications or medical weight loss programs to bariatric surgery is a proactive, informed choice not a last resort
Retatrutide is a once-weekly subcutaneous GIPR/GLP-1R/GCGR triple receptor agonist
we plan for keeping it off from day one
The study was originally published online in the International Journal of Antimicrobial Agents on March 20, 2020